FFO
NUVB icon

Fortitude Family Office’s Nuvation Bio NUVB Stock Holding History

Fortitude Family Office’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339 Hold
79
– – ﹤0.01% 1814
2025
Q4 		$708 Hold
79
– – ﹤0.01% 1585
2025
Q3 		$292 Hold
79
– – ﹤0.01% 1904
2025
Q2 		$154 Sell
79
-302
-79% -$629 ﹤0.01% 1980
2025
Q1 		$671 Hold
381
– – ﹤0.01% 1062
2024
Q4 		$1.01K Hold
381
– – ﹤0.01% 1139
2024
Q3 		$872 Hold
381
– – ﹤0.01% 1114
2024
Q2 		$1.11K Hold
381
– – ﹤0.01% 874
2024
Q1 		$1.39K Hold
381
– – ﹤0.01% 874
2023
Q4 		$575 Buy
+381
New +$490 ﹤0.01% 973

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fortitude Family Office's NUVB Position: Q1 2026 in Review

Fortitude Family Office held its Nuvation Bio (NUVB) position steady in Q1 2026 at 79 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Fortitude Family Office first reported a position in NUVB in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.39K in Q1 2024. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Fortitude Family Office held 79 shares of Nuvation Bio worth $339 as of Q1 2026.
  • Fortitude Family Office left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1814 holding.
  • Fortitude Family Office first reported a position in Nuvation Bio in Q4 2023 and has held it in 10 quarters since.
  • Fortitude Family Office's Nuvation Bio position peaked at $1.39K in Q1 2024.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.